Fintel reports that on December 4, 2025, Scotiabank maintained coverage of Bristol-Myers Squibb (NYSE:BMY) with a Sector ...
Dow Jones Top Company Headlines at 5 PM ET: Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 Million | Snowflake ... Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 ...
Bristol-Myers Squibb shares gained after the company announced that it will enroll additional patients in the ADEPT-2 study.
The Prudent Speculator is an investment newsletter that has been published monthly since 1977. Buckingham and his team run four value-stock portfolios. The flagship Prudent Speculator Portfolio has ...
Monday rejected Bristol Myers Squibb's bid to dismiss a $6.7 billion lawsuit claiming it cheated shareholders of the former ...
Pre-tax profits at the main Irish unit of pharma giant, Bristol Myers Squibb last year declined by 47% to $2.09 billion ...
Pfizer(NYSE: PFE) and Bristol Myers Squibb(NYSE: BMY) are two of the largest and most respected pharmaceutical companies in ...
Bayer reported positive Phase 3 results for its FXIa inhibitor asundexian, hitting key efficacy and safety targets ...
The Schwab U.S. Dividend Equity ETF currently trades at about $27 per share. So, your $500 will buy you about 18 shares. The ...
Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline.
Bristol Myers Squibb has struggled over the past few years due to patent cliffs. And to make matters worse, it will soon face ...
Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback